Form 8-K - Current report:
SEC Accession No. 0001193125-25-140339
Filing Date
2025-06-13
Accepted
2025-06-13 08:00:29
Documents
12
Period of Report
2025-06-12
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d98388d8k.htm   iXBRL 8-K 26754
  Complete submission text file 0001193125-25-140339.txt   141194

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA urgn-20250612.xsd EX-101.SCH 2841
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE urgn-20250612_lab.xml EX-101.LAB 17994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE urgn-20250612_pre.xml EX-101.PRE 11255
14 EXTRACTED XBRL INSTANCE DOCUMENT d98388d8k_htm.xml XML 3644
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38079 | Film No.: 251044772
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)